Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
22.16
+6.42 (40.79%)
At close: Mar 9, 2026, 4:00 PM EDT
22.05
-0.11 (-0.50%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Hims & Hers Health Revenue
In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth. Hims & Hers Health had revenue of $617.82M in the quarter ending December 31, 2025, with 28.41% growth.
Revenue (ttm)
$2.35B
Revenue Growth
+59.00%
P/S Ratio
2.15
Revenue / Employee
$961,358
Employees
2,442
Market Cap
5.05B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.72B |
| Dr. Reddy's Laboratories | 3.85B |
| Amneal Pharmaceuticals | 3.02B |
| Lantheus Holdings | 1.54B |
| Alkermes | 1.48B |
| Prestige Consumer Healthcare | 1.10B |
| BioCryst Pharmaceuticals | 874.84M |
| Supernus Pharmaceuticals | 718.95M |
HIMS News
- 2 hours ago - Hims & Hers: Not Selling Yet - Seeking Alpha
- 3 hours ago - Hims & Hers Health: The Juice Is Worth The Squeeze - Seeking Alpha
- 4 hours ago - Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze? - Benzinga
- 6 hours ago - Hims & Hers stock: why today's gains are unlikely to be sustainable - Invezz
- 7 hours ago - Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS - Business Wire
- 8 hours ago - Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why - Fast Company
- 9 hours ago - Hims & Hers Stock Pops on a Deal With Rival Novo Nordisk—What You Need to Know - Investopedia
- 10 hours ago - Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal - Invezz